Original Article

Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection
  • Mahmut Kaya
  • Ferit Hakan Öner
  • Betül Akbulut Yağcı
  • Ferdane Ataş
  • Taylan Öztürk
Turk J Ophthalmol 2021; 51: 32-37 DOI: 10.4274/tjo.galenos.2020.84042 PMID:33631912
Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
  • Müge Çoban Karataş
  • Gürsel Yılmaz
  • Aslıhan Yüce Sezen
  • Çağla Sarıtürk
Turk J Ophthalmol 2022; 52: 45-49 DOI: 10.4274/tjo.galenos.2021.75608 PMID:35196839
Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
  • Serhad Nalçacı
  • Cezmi Akkın
  • Filiz Afrashi
Turk J Ophthalmol 2019; 49: 73-77 DOI: 10.4274/tjo.galenos.2018.84665 PMID:31055891
The Effects of Anti-Vascular Endothelial Growth Factor Drugs on Retinal Pigment Epithelial Cell Culture
  • Mustafa Şahiner
  • Dilek Bahar
  • Ayşe Öner
  • Zeynep Burçin Gönen
  • Metin Ünlü
  • Duygu Gülmez Sevim
  • Çağatay Karaca
  • Galip Ertuğrul Mirza
Turk J Ophthalmol 2018; 48: 190-195 DOI: 10.4274/tjo.20270 PMID:30202615
Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1
  • Abdullah Özkaya
  • Levent Karabaş
  • Cengiz Alagöz
  • Zeynep Alkın
  • Özgür Artunay
  • Selim Bölükbaşı
  • Gökhan Demir
  • Mehmet Demir
  • Ali Demircan
  • Burak Erden
  • Gürkan Erdoğan
  • Mehmet Erdoğan
  • Erdem Eriş
  • Havva Kaldırım
  • İsmail Umut Onur
  • Özen Osmanbaşoğlu
  • Sezin Özdoğan Erkul
  • Mine Öztürk
  • İrfan Perente
  • Kübra Sarıcı
  • Nihat Sayın
  • Dilek Yaşa
  • İhsan Yılmaz
  • Zeynep Yılmazabdurrahmanoğlu
Turk J Ophthalmol 2018; 48: 232-237 DOI: 10.4274/tjo.31697 PMID:30405944
Risk-based Algorithm-guided Treatment Protocol for the Management of Neovascular Age-related Macular Degeneration
  • Murat Karaçorlu
  • Mümin Hocaoğlu
  • Serra Arf
  • M. Giray Ersöz
  • Işıl Sayman Muslubaş
Turk J Ophthalmol 2019; 49: 258-269 DOI: 10.4274/tjo.galenos.2019.26235 PMID:31650792
Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration
  • Mine Esen Barış
  • Jale Menteş
  • Filiz Afrashi
  • Serhad Nalçaçı
  • Cezmi Akkın
Turk J Ophthalmol 2020; 50: 275-282 DOI: 10.4274/tjo.galenos.2020.38488 PMID:33342194
Application of Topical/Subconjunctival Bevacizumab and Topical Fluorometholone Acetate in Alkali Burn-induced Model of Corneal Angiogenesis
  • Ayşen Topalkara
  • Mustafa İlker Toker
  • Feyza Dursun
  • Ayşe Vural Özeç
  • Mustafa Kemal Arıcı
  • Ayhan Dursun
Turk J Ophthalmol 2010; 40: 318-322 DOI: 10.4274/tjo.40.318
The Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Macular Edema Related to Retinal Vein Occlusion: Real-life Data and Prognostic Factors in a Turkish Population
  • Ayşe Yağmur Kanra
  • Aylin Ardagil Akçakaya
  • Sevil Arı Yaylalı
  • Meltem Güzin Altınel
  • Neslihan Sevimli
Turk J Ophthalmol 2017; 47: 331-337 DOI: 10.4274/tjo.75317 PMID:29326850
Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema
  • Kai Xiong Cheong
  • Shu Yen Lee
  • Marcus Ang
  • Kelvin Yi Chong Teo
Turk J Ophthalmol 2020; 50: 343-350 DOI: 10.4274/tjo.galenos.2020.81592 PMID:33389934

Case Report

Treatment Approach to Autosomal Recessive Dystrophic Epidermolysis Bullosa
  • Rana Altan Yaycıoğlu
  • Yonca Aydın Akova
  • Fatma Selin Kaya
  • Sibel Oto
Turk J Ophthalmol 2010; 40: 107-112

Case Report

Unusual Association of Inverse Retinitis Pigmentosa, Scleromalacia, and Neovascular Glaucoma
  • Ayşe Gül Koçak Altıntaş
  • Çağrı İlhan
  • Mehmet Çıtırık
Turk J Ophthalmol 2020; 50: 110-114 DOI: 10.4274/tjo.galenos.2020.07573 PMID:32367703

Original Article

Factors Affecting Compliance to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration
  • Onur Polat
  • Sibel İnan
  • Serkan Özcan
  • Mustafa Doğan
  • Tuncay Küsbeci
  • Güliz Fatma Yavaş
  • Ümit Übeyt İnan
Turk J Ophthalmol 2017; 47: 205-210 DOI: 10.4274/tjo.28003 PMID:28845324